Abstract
Menopausal transition is characterized by ovarian failure and its consequent decrease in female sex steroid production. Earlier studies suggest that an increase and redistribution of body fat during menopause predispose women to cardiovascular disease and metabolic syndrome. In addition, peri- and post-menopausal women seem to have less lean body mass (LBM) compared with pre-menopausal women. Accordingly, a changing ovarian hormonal status may accelerate the loss of muscle mass and result in decreased muscle performance and functional capacity. Hormone replacement therapy (HRT) has been used to treat menopausal symptoms and as a primary prevention therapy in chronic conditions. Inconsistent findings have, however, been published on the effects of HRT on body composition in postmenopausal women. Some studies clearly suggest that HRT counteracts menopause-related changes in body composition whereas others fail to show any difference between post-menopausal HRT users and abstainers. Although cross-sectional studies show conflicting results concerning the association between HRT and muscle performance, experimental trials suggest that deterioration in muscle force during menopause can be prevented by HRT. In the future, longitudinal data need to be collected to confirm changes in body composition and muscle performance during menopausal transition irrespective of age. Although HRT seems to have beneficial effects on body composition and muscle performance in healthy post-menopausal women, there is considerable variation in the effects of HRT between different studies. The underlying mechanism of HRT action on muscle performance is still unclear.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lamberts SWJ, van den Beld AW, van den Lely AJ. The endocrinology of aging. Science 1997, 278: 419–24.
Rannevik G, Carlström K, Jeppsson S, Bjerre B, Svanberg L. A prospective long-term study in women from pre-menopause to post-menopause: changing profiles of go-nadotrophins, oestrogens and androgens. Maturitas 1986, 8: 197–307.
Cauley JA, Zmuda JM, Ensrud KE, Bauer DC, Ettinger B. Timing of estrogen replacement therapy for optimal osteoporosis prevention. J Clin Endocrin Metab 2001, 86: 5700–5.
Mosca L, Collines P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 2001, 104: 499–503.
Snieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman’s reproductive life: A twin study of hysterectomy and age at menopause. J Clin Endocr Metab 1998, 83: 1875–80.
Wise PM, Krajnak KM, Kashon ML. Menopause: The aging of multiple pacemakers. Science 1996, 273: 67–70.
Douchi T, Yamamoto S, Yoshimitsu N, Andoh T, Matsuo T, Nagata Y Relative contribution of aging and menopause to changes in lean and fat mass in segmental regions. Maturitas 2002, 42: 301–6.
Gambacciani M, Ciaponi M, Cappagli B, Benussi C, De Simone L, Genazzani AR. Climacteric modifications in body weight and fat tissue distribution. Climacteric 1999, 2: 37–44.
Svendsen OL, Hassager C, Christiansen C. Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy x-ray absorptiometry. Metabolism 1995, 44: 369–73.
Toth MJ, Tchernof A, Sites CK, Poehlman ET. Effects of menopausal status on body composition and abdomina fat distribution. Int J Obesity 2000, 24: 226–31.
Trémollieres FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol 1996, 175: 1594–600.
Panotopoulos G, Ruiz JC, Raison J, Guy-Grand B, Basdevant A. Menopause, fat and lean distribution in obese women. Maturitas 1996, 25: 11–9.
Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: A controlled longitudinal study. Ann Intern Med 1995, 123: 673–5.
Wang Q, Hassager C, Ravn P, Wang S, Christiansen C. Total and regional body-composition changes in early postmenopausal women: age-related or menopause-re-lated. Am J Clin Nutr 1994, 60: 843–8.
Lexell J, Taylor CC, Sjostrom M. What is the cause of the aging atrophy. Total number, size and proportion of different fiber types studied in whole lastus lateralis muscle from 15-to 83-year-old men. J Neurol Sci 1988, 84: 275–94.
Kovanen V, Suominen H, Peltonen L, et al. Effects of aging and life-long physical training on collagen in slow and fast skeletal muscle in rats. A morphometric and im-munohistochemical study. Cell Tissue Res 1987, 248: 247–55.
Douchi T, Yamamoto S, Nakamura S, et al. The effects of menopause on regional and total body lean mass. Maturitas 1998, 29: 247–52.
Rantanen T, Masaki K, Foley D, Izmirlian G, White L, Guralnik JM. Grip strength changes over 27 yr in Japanese-American men. J Appl Physiol 1998, 85: 2047–53.
Bassey EJ, Harries UJ. Normal values for hand grip strength in 920 men and women aged over 65 years, and longitudinal changes over 4 years in 620 survivors. Clin Sci 1993, 84: 331–7.
Skelton DA, Greig CA, Davies JM, Young A. Strength, power and related functional ability of healthy people aged 65–89 years. Age Aging 1994, 23: 371–7.
Samson MM, Meeuwsen IBAE, Crowe A, Dessens AG, Duursma SA, Verhaar HJJ. Relationship between physica performance measures, age, height and body weight in healthy adults. Age Aging 2000, 29: 135–242.
Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci 1993, 84: 95–8.
Lindle RS, Metter EJ, Lynch NA, et al. Age and gender comparisons of muscle strength in 654 women and men aged 20–93 yr. J Appl Physiol 1997, 83:1581–7.
Lynch NA, Metter EJ, Lindle RS, et al. Muscle quality. I. Age-associated differences between arm and leg muscle groups. J Appl Physiol 1999, 86: 188–94.
Dittmar M. Comparison of soft tissue body composition in postmenopausal women with and without hormone replacement therapy considering the influence of reproductive history and lifestyle. Ann Hum Biol 2001, 28: 207–21.
Kahlert S, Grohé C, Karas RH, Löbbert K, Neyses L, Vetter H. Effects of estrogen on skeletal myoblast growth. Biochem Bioph Res Co 1997, 232: 373–8.
Site CK, Brochu M, Tchernof A, Poehlman ET. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausa women. Metabolism 2001, 50: 835–40.
Gower BA, Nyman L. Association among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women. J Clin Endocr Metab 2000, 85: 4476–80.
Bemben DA, Lagdon DB. Relationship between estrogen use and musculoskeletal function in postmenopausal women. Maturitas 2002, 42: 119–27.
Taaffe DR, Villa ML, Delay R, Marcus R. Maximal muscle strength of elderly women is not influenced by oestrogen status. Age Aging 1995, 24: 329–33.
Davis S, Walker KZ, Strauss BJG. Effects of estradiol with and without testosterone on body composition and relationship with lipids in postmenopausal women. Menopause 2000, 7: 395–401.
Gambacciani M, Ciaponi M, Cappagli B, De Simone L, Orlandi R, Gennazzani AR. Prospective evaluation of body weight and body fat distribution in early postmenopausa women with and without hormonal replacement therapy. Maturitas 2001, 39: 125–32.
Sørensen MB, Rosenfalck AM, Højgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res 2001, 9: 622–6.
Aloia JF, Vaswani A, Russo L, Sheehan M, Flaster E. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 1995, 172: 896–900.
Reubinoff BE, Wurtman J, Rojansky N, et al. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steri 1995, 64: 963–8.
Sipilä S, Taaffe D, Cheng S, Puolakka J, Toivanen J, Suominen H. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in postmenopausal women: a randomized placebo-controlled study. Clin Sci 2001, 101: 147–57.
Walker RJ, Lewis-Barned NJ, Sutherland WHF, et al. The effects of sequential combined oral 17β-estradio norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study. Menopause 2001, 8: 27–32.
Jensen J, Christiansen C, Rødbor P. Oestrogen-progesto-gen replacement therapy changes body composition in early post-menopausal women. Maturitas 1986, 8: 209–16.
Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989, 129: 1120–31.
Cauley JA, Petrini AM, LaPorte RE, et al. The decline of grip strength in the menopause: Relationship of physica activity, estrogen use and anthropometric factors. J Chron Dis 1987, 40: 115–20.
Seeley DG, Cauley JA, Grady D, Browner WS, Nevitt MC, Cummings SR. Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women? Arch Intern Med 1995, 155: 293–9.
Greeves JP, Cable NT, Reilly T, Kingsland C. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci 1999, 97: 79–84.
Heikkinen J, Kyllönen E, Kurttila-Matero E, et al. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective tria on two estrogen-progestin regimens in healthy postmenopausal women. Maturitas 1997, 26: 139–49.
Skelton DA, Phillips SK, Bruce SA, Naylor CH, Woledge RC. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausa women. Clin Sci 1999, 96: 357–64.
Skelton DA, Young A, Greig CA, Malbut KE. Effects of resistance training on strength, power, and selected functional abilities of women aged 75 and older. J Am Geriatr Soc 1995, 43: 1081–7.
Albertazzi P, Purdie DW. The life and time of the estrogen receptors: an interim report. Climacteric 2001, 4: 194–202.
Saartok T. Steroid receptor in two types of rabbit skeleta muscle. Int J Sports Med 1984, 5: 130–6.
Dahlberg E. Characterization of the cytosolic estrogen receptor in rat skeletal muscle. Biochim Biophys Acta 1982, 717: 65–75.
Dionne FT, Dube JY, Frenette G, Tremblay RR. Effects of endocrine manipulations on oestrogen binding in cytosols from rat skeletal and perineal muscle. J Endocrinol 1980, 85: 351–8.
Dube JY, Lesage R, Tremblay RR. Androgen and estrogen binding in rat skeletal and perineal muscle. Can J Biochem 1976, 54: 50–5.
Meyer HH, Rapp M. Estrogen receptor in bovine skeleta muscle. J Anim Sci 1985, 60: 294–300.
Pfaffl MW, Lange IG, Daxenberger A, Meyer HHD. Tissue-specific expression pattern of estrogen receptors (ES): Quantification of ERα and ERβ mRNA with real-time RT-PCR. APMIS 2001, 109: 345–55.
Saartok T, Dahlberg E, Bylund P, Eriksson E, Gustafsson J-Å. Steroid hormone receptors, protein, and DNA in erector spinae muscle from scoliotic patients. Clin Orthop 1984, 197–207.
Rance NE, Max SR. Modulation of the cytosolic androgen receptor in striated muscle by sex steroids. Endocrinology 1984, 115: 862–6.
Puah JA, Bailey CJ. Effects of ovarian hormones on glucose metabolism in mouse soleus muscle. Endocrinology 1985, 117: 1336–40.
Joe I, Ramirez VD. Binding of estrogen and progesterone-BSA conjugates to glyseraldehyde-3-phosphate dehydrogenase (GAPDH) and the effects of the free steroids on GAPDH enzyme activity: physiological implications. Steroids 2001, 66: 529–38.
Dragovic T, Minhall R, Jackman HL, Wang L-X, Erdos EG. Kininase II-type enzymes: their putative role in muscle energy metabolism. Diabetes 1996, 45: S34–7.
Montgomery H, Clarkson P, Barnard M, et al. Angiotensin-converting-enzyme gene insertion/depletion polymorphism and response to physical training. Lancet 1999: 353: 541–5.
Woods D, Onambele G, Woledge R, et al. Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density. J Clin Endocr Metab 2001, 86: 2200–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sipilä, S. Body composition and muscle performance during menopause and hormone replacement therapy. J Endocrinol Invest 26, 893–901 (2003). https://doi.org/10.1007/BF03345241
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345241